Lotus Eye Hospital And Institute Ltd - 532998 - Reconciliation Of Share Capital Audit For The Quarter Ended 31.03.2023 As Per Regulation 76 Of The SEBI (DP) Regulation,2018
We are enclosing herewith the Reconciliation of Share Capital Audit Report for the quarter ended 31st March 2023 as per Regulation 76 of the SEBI (Depositories and Participants) Regulation 2018 and in terms of Circular No. CIR/MRD/DP/30/2010 dated 06.09.2010 issued by SEBI. Lotus Eye Hospital And Institute Ltd - 532998 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Based on the confirmation received from S.K.D.C. Consultants Limited, Registrar and Transfer Agent of the company, we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within 15 days of receipt of certificate of security and the details are furnished to the stock exchanges. Further, we, certify that the securities which were dematerialized are listed on the Stock Exchanges where the earlier issued securities are listed. Lotus Eye Hospital And Institute Ltd - 532998 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Pursuant to Regulation 7(3) of of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby enclose the compliance certificate duly signed by the company secretary of Lotus Eye Hospital and Institute Limited and the Authorised Representative of the Share transfer agent for the Financial year ended on 31.03.2023. Lotus Eye Hospital And Institute Ltd - 532998 - Closure of Trading Window
This is to inform you that as per the SEBI (Prohibition of Insider trading ) regulations 2015 read with BSE Circular Ref No LIST/COMP/01/2019-20 and as per the terms of Code of Internal Procedures and conduct for regulating Monitoring and Reporting of Trading by Insider''s of the company, the trading window for dealing in the Company shares will remain closed from April 1st , 2023 till the end of 48 hours after declaration of audited financial results for the quarter and financial year ending on 31st March 2023 for specified designated persons as defined in the code. The same has been informed to the Directors and designated persons of the Company. The date of Board Meeting for declaration of the financial results of the Company for the quarter and financial year ended March 31st 2023 will be intimated in the due course. Lotus Eye Hospital And Institute Ltd - 532998 - Results Of Voting By Postal Ballot And Scrutinizer'S Report
Pursuant to regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) 2015 read with Section 110 of Companies Act 2013 and Rule 22 of Companies (Management and Administration) Rules 2014 and with reference to intimation dated 16.02.2023 of the Postal ballot notice seeking approval of shareholders for appointment of Mr Karthik Veeramani (DIN: 07097588) and Perumalsamy Mahendran (DIN: 06680557) as Independent Directors of the Company We hereby attach the voting results and scrutinizers report issued by M/s P Eswaramoorthy Company Secretaries Coimbatore. Both the resolutions has been passed with requisite majority and the resolutions shall be deemed to be passed on 18.03.2023. The Voting Results along with the Scrutinizer's Report are also being made available on the Company's website at https://www.lotuseye.org/about-us/investors. Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed the copies of the Newspaper Advertisement published in newspapers Business standard (English) all India Edition and Dina Mani (Tamil) Coimbatore Edition, on Friday, February 17, 2023, the notice of Postal Ballot and information on Remote E-voting for seeking approval of Members of the Company on the Special Businesses as mentioned in the notice of the Postal Ballot. Lotus Eye Hospital And Institute Ltd - 532998 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Regulation 30 of SEBI (LODR) 2015, please find attached the Postal Ballot Notice seeking approval of the Members of the Company for the appointment of Mr Karthik Veeramani (DIN: 07097588) and Mr Perumalsamy Mahendran (DIN: 06680557) as Non-Executive Independent Director of the Company by means of Postal Ballot by voting through electronic means(Remote E-voting). The Notice is being sent to all the Members, whose names appear in the Register of Members/ List of Beneficial Owners as on Tuesday 14.02.2023 (i.e., cut-off date) as received from S.K.D.C Consultants Limited, Registrar and Share Transfer Agents of the Company. Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copy of Newspaper Advertisement published on February 14th and February 15th, 2023 in Tamil Murasu (Coimbatore Edition) and Business Standard (All India Edition) in respect of financial results approved by the Board at its meeting held on February 13, 2023. Lotus Eye Hospital And Institute Ltd - 532998 - Appointment Of Perumalsamy Mahendran As Additional Director Classified As An Independent Director Subject To Approval Of Shareholders
Pursuant to Regulation 30(2) read with Schedule III Part A Para 7 of SEBI (Listing Obligation and Disclosures Requirements) 2015, The board of Directors in its meeting held on 13.02.2023, subsequent to the recommendation of Nomination and Remuneration committee, have appointed Perumalsamy Mahendran holding (DIN: 06680557) as an Additional Director classified as an Independent Director with effect from 13.02.2023 subject to approval of shareholders either through Extra-ordinary General Meeting or Postal ballot. Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30(2) read with Schedule III Part A Para 7 of SEBI (Listing Obligation and Disclosures Requirements) 2015, The board of Directors in its meeting held on 13.02.2023, subsequent to the recommendation of Nomination and Remuneration committee, have appointed Perumalsamy Mahendran holding (DIN: 06680557) as an Additional Director classified as an Independent Director with effect from 13.02.2023 subject to approval of shareholders either through Extra-ordinary General Meeting or Postal ballot.